Sun Pharma, Cadila Healthcare recall products from US market

The US-based subsidiaries of two domestic drug firms -- Sun Pharma and Cadila Healthcare -- are recalling one product each from the market on account of failure to meet the desired specification norms.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol

Home » News » Business

Nov 30, 2016, 07.53 PM | Source: PTI

Sun Pharma, Cadila Healthcare recall products from US market

The US-based subsidiaries of two domestic drug firms -- Sun Pharma and Cadila Healthcare -- are recalling one product each from the market on account of failure to meet the desired specification norms.

Like this story, share it with millions of investors on M3

Sun Pharma, Cadila Healthcare recall products from US market

The US-based subsidiaries of two domestic drug firms -- Sun Pharma and Cadila Healthcare -- are recalling one product each from the market on account of failure to meet the desired specification norms.

Post Your Comments

Share Cancel

| 1 Comments
Sun Pharma, Cadila Healthcare recall products from US market
The US-based subsidiaries of two domestic drug firms -- Sun Pharma and Cadila Healthcare -- are recalling one product each from the market on account of failure to meet the desired specification norms.

Zydus Pharmaceuticals USA Inc is recalling 2,472 units of Bupropion Hydrochloride extended release tablets manufactured by Ahemdabad-based Cadila Healthcare, the latest Enforcement Report of the USFDA has said.

Bupropion Hydrochloride extended-release tablets, USP (XL) 300 mg are being recalled by Zydus Pharmaceuticals USA Inc on account of "Failed Dissolution Specifications: product did not meet dissolution specification at an intermediate time point", it added.

The ongoing nationwide recall is a class III recall, it added.

Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder.

Sun Pharmaceutical Industries Inc, the US arm of drug major Sun Pharma is recalling 326,103 bottles of Kenalog (Triamcinolone Acetonide) spray with spray tube topical Aerosol on account of failed stability specifications.

The class III ongoing recall of the product in the strength of 0.147 mg/g, 15 g bottle, that is a physician sample and not for sale is due to ,"low out of specification results for alcohol content," the report said.

Kenalog spray is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

As per the United States Food and Drug Administration (USFDA), a class III recall is initiated in a "situation in which use of or exposure to a violative product is not likely to cause adverse health consequences".

Buy, Hold, Sell ? Hear it first on M3
Sun Pharma, Cadila Healthcare recall products from US market

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login